Letter from the Editor

The 2014 PharmaVOICE 100
The PharmaVOICE 100 Turns 10!

It’s hard to believe that 10 years after the vision for this issue was captured on the back of a napkin during a long flight delay, we have now profiled 1,000 of the industry’s most inspirational and motivational individuals making this issue one of the industry’s hallmark editions. In conjunction with this milestone anniversary, we are excited to announce the Red Jacket award, which is our twist on a hall of fame. We have selected six outstanding individuals to mark this inaugural award. (Please turn to the Red Jacket award section to read their profiles.) Their selection was based on a number of factors, including having been named to the PharmaVOICE 100 on several occasions over the past nine years. But, more importantly, these six individuals are true visionaries and are dedicated to reshaping their sector of the healthcare ecosystem. They are innovators and they are great leaders. And, like all of our PharmaVOICE 100 honorees, they give back to their communities here and abroad.

This special issue is our opportunity to give back to the industry and share the remarkable and inspirational stories of the individuals who are dedicated to their teams, their organizations, the patients they serve, and the healthcare arena overall.
Once again, we are showcasing the individuals as identified by you, our readers, for being outstanding leaders in guiding their teams and companies to success; they are innovators — creating new opportunities and visionary products and companies to address the future of healthcare; and philanthropists — giving back personally and through their companies to local, national, and global organizations that provide goods and services to communities and patients in need.
In addition to the thoughtful profiles showcasing each individual, we have compiled several informative articles that address the topics of innovation, challenges and opportunities, and mentoring, which can only be found online in our bonus content; so please log onto pharmavoice.com to read more from our PharmaVOICE 100 honorees.

To navigate this special publication, which has become known as the feel-good issue of the year, we have divided the honorees into categories that we believe best capture their expertise, which is no easy feat as each could easily fit into several of the following sections: academics, commanders and chiefs, creatives, entrepreneurs, clinical specialists, researchers and scientists, marketers, patient advocates, mentors, strategists, and technologists.

With thousands of nominations to consider, we rely on the personal accounts from our readers that describe why these individuals are special. Thanks to all of you who took time out of your busy schedules to nominate the individuals who have made, and continue to make, a difference in your careers, lives, and organizations. We also want to thank all of our PharmaVOICE 100 honorees for taking the time to share their personal stories with us. Please join us in extending warm congratulations to this esteemed group.

Regards,
Taren Grom, Editor
[email protected]

Their Word…

Denise Myshko
Managing Editor
Many of the PharmaVOICE 100 were excited that data and technology changes will bring positive results to the industry.

Robin Robinson
Senior Editor
Recognizing this year’s PharmaVOICE 100 nominees has been a lesson in humility, knowledge, innovation, and cutting edge leadership.

Kim Ribbink
Features Editor
Breaking barriers, overcoming obstacles, finding solutions and cures, and bringing people together to achieve all these goals in collaborative ways — these achievements and more are what make this year’s PharmaVOICE 100 honorees so inspirational.

Coming in September 2014

Digital Patients
Brand Identity
Nanotech Medicines
Managed Markets
Biosimilars
The C-Suite: Outsourcing
Market Sector: Chile
Showcase Feature: Marketing
Showcase Feature: Data Management & Health Information Services

The forum for the industry executive
Volume 14 • Number 7

Publisher – Lisa Banket
Editor Taren – Grom
Creative Director – Marah Walsh

Managing Editor – Denise Myshko
Senior Editor – Robin Robinson
Features Editor – Kim Ribbink
Design Associate – Ariel Medel
Director of Sales – Cathy Tracy
National Account Manager – Suzanne Besse
Webcast?Network?Producer – Daniel Limbach
Circulation Assistant – Kathy Deiuliis

PharmaVOICE (ISSN: 1932961X) is published monthly except joint issues in July/Aug. and Nov./Dec., by PharmaLinx LLC, P.O.?Box 327, Titusville, NJ 08560. Periodicals postage paid at Titusville, NJ 08560 and additional mailing offices.

Postmaster: Send address changes to PharmaVOICE, P.O. Box 292345, Kettering, OH 45429-0345.

PharmaVOICE Coverage and Distribution:
Domestic subscriptions are available at $190 for one year (10 issues). Foreign subscriptions: 10 issues US$360. Contact PharmaVOICE at P.O.?Box 327, Titusville, NJ 08560. Call us at 609.730.0196 or FAX your order to 609.730.0197.

Contributions: PharmaVOICE is not responsible for unsolicited contributions of any type. Unless otherwise agreed in writing, PharmaVOICE retains all rights on material published in PharmaVOICE for a period of six months after publication and reprint rights after that period expires. E-mail: [email protected].

Change of address: Please allow six weeks for a change of address. Send your new address along with your subscription label to PharmaVOICE, P.O. Box 292345, Kettering, OH 45429-0345. Call us at 800.607.4410 or FAX your change to 937.890.0221. E-mail: [email protected].

IMPORTANT NOTICE: The post office will not forward copies of this magazine. PharmaVOICE is not responsible for replacing undelivered copies due to lack of or late notification of address change.

Advertising in PharmaVOICE: To advertise in PharmaVOICE please contact our Advertising Department at P.O.?Box 327, Titusville, NJ 08560, or telephone us at 609.730.0196. E-mail: [email protected].

Letters:
Send your letters to [email protected]. Please include your name, title, company, and business phone number. Letters chosen for publication may be edited for length and clarity. All submissions become the property of PharmaLinx LLC.

Download PDF